PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions
Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) An Imaging Study in Patients With Unstable Atherosclerotic Lesions
Sponsor: Abbott Medical Devices
A observational or N/A phase clinical study on Coronary Artery Disease and Coronary Disease, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 12 data snapshots since 2004. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Dec 2018 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Dec 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Oct 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalst, Belgium , Aarhus, Denmark , Antwerp, Belgium , Atlanta, United States , Bad Nauheim, Germany , Bad Oeynhausen, Germany , Besançon, France , Bologna, Italy , Boston, United States , Carnaxide, Spain and 28 more locations